Nektar Therapeutics (NKTR) Is Still Worth A Look Despite -27.90% Fall From High
Nektar Therapeutics (NASDAQ:NKTR) concluded the trading at $1.39 on Wednesday, November 06 with with a fall of -0.71% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.40 and 5Y monthly beta